LYFIX Mutual Fund (AlphaCentric Life Sciences and Healthcare Fund Class I) is managed by Alpha Centric Fund with $39.6M in net assets. LYFIX expense ratio is 1.46%, holding 63 positions across sectors including Health Care, Unknown, Financials. Inception date: 2019-11-29.

LYFIX performance shows a YTD return of 18.10%. The 1-year return is 54.67% and the 5-year return is 8.75%. LYFIX dividend yield stands at 1.52%, paid annually.

LYFIX top holdings include First Am Treas Obli-X (7.7%), Gilead Sciences Inc (7.2%), Astrazeneca Plc (5.6%), Nvaesrtex Pharmaceuticals Inc (5.6%), Ionis Pharmaceuticals Inc (3.7%). View all LYFIX holdings, sector breakdown, or dividend history.

LYFIX can be compared against other funds using the overlap calculator or side-by-side comparison tool. LYFIX alternatives are available via the screener, along with tax-loss harvesting opportunities.